Position in JNJ
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$3,793,549
-$140,223 QoQ
Shares Held
14,937
-7.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.58%
of 13F equity value
Holder Rank
#1,819
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Wealth Alliance Advisory Group, LLC holds $19,374,550 across 10 Drug Manufacturers - General names. JNJ ranks #2 (19.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
6,285 | $7,538,418 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
14,937 | $3,793,549 | |
| 3 | ABBV |
AbbVie Inc.
|
11,481 | $2,889,078 | |
| 4 | AMGN |
Amgen Inc
|
5,753 | $2,083,276 | |
| 5 | MRK |
Merck & Co., Inc.
|
8,319 | $1,068,991 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
15,689 | $904,000 | |
| 7 | NVS |
Novartis AG
|
2,100 | $329,112 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,345 | $296,267 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,793,549 | 14,937 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $3,933,772 | 16,093 | Shares | Sole | 2026-04-09 | |
| 2025-12-31 | $1,817,227 | 8,781 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $1,663,773 | 8,973 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $2,281,474 | 14,936 | Shares | Sole | 2025-07-07 | |
| 2025-03-31 | $1,631,533 | 9,838 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $2,136,615 | 14,774 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $2,442,568 | 15,072 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $2,241,948 | 15,339 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $2,836,663 | 17,932 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $2,716,774 | 17,333 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $2,941,027 | 18,883 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $2,917,455 | 17,626 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $2,731,875 | 17,625 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $3,245,060 | 18,370 | Shares | Sole | 2023-01-17 | |
| 2022-09-30 | $2,937,539 | 17,982 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $2,988,380 | 16,835 | Shares | Sole | 2022-07-08 | |
| 2022-03-31 | $2,761,952 | 15,584 | Shares | Sole | 2022-04-18 | |
| 2021-12-31 | $3,007,239 | 17,579 | Shares | Sole | 2022-01-13 | |
| 2021-09-30 | $2,517,300 | 15,587 | Shares | Sole | 2021-10-08 | |
| 2021-06-30 | $2,530,241 | 15,359 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $2,626,148 | 15,979 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $2,517,293 | 15,995 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $2,295,134 | 15,416 | Shares | Sole | 2020-10-08 | |
| 2020-06-30 | $2,166,967 | 15,409 | Shares | Sole | 2020-07-08 | |
| 2020-03-31 | $2,002,223 | 15,269 | Shares | Sole | 2020-04-15 | |
| No filing history on record for this holder in this stock. | ||||||